WHO-GMP Certified Commercial Pack · Product Code: AKP-047
Ceftriaxone Sodium 750mg & Sulbactam Sodium 375mg Injection
Formulation Overview: Intermediate 1.125 g parenteral cephalosporin/beta-lactamase inhibitor combination vial supporting broad aerobic-anaerobic empirical antimicrobial coverage. Formulated with Ceftriaxone Sodium IP (eq. 750 mg) + Sulbactam Sodium IP (eq. 375 mg) (750 mg + 375 mg (1.125 g)) in Sterile Dry Powder Injection Vial dosage form under Anti-Infectives & Antibiotics, manufactured to IP / BP / USP Compendial standards and supplied in 1.125 g USP Type I Glass Vial + 10 ml Sterile WFI Ampoule with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-047 |
|---|---|
| Therapeutic Sector | Anti-Infectives & Antibiotics |
| Dosage Form | Sterile Dry Powder Injection Vial |
| Active Ingredient | Ceftriaxone Sodium IP (eq. 750 mg) + Sulbactam Sodium IP (eq. 375 mg) |
| Strength / Purity | 750 mg + 375 mg (1.125 g) |
| Clinical Indication | Moderate-to-severe intra-abdominal infections, lower respiratory tract infections, and post-operative sepsis |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 1.125 g USP Type I Glass Vial + 10 ml Sterile WFI Ampoule |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from light |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |